New patent for Cmp Dev drug TADLIQ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for TADLIQ
Annual Drug Patent Expirations for TADLIQ

Tadliq is a drug marketed by Cmp Dev Llc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has nine patent family members in nine countries.

The generic ingredient in TADLIQ is tadalafil. One supplier is listed for this compound. Additional details are available on the tadalafil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top